Defiance Daily Target 2X Long NVO ETF (NVOX)

NYSEARCA: NVOX · Real-Time Price · USD
12.64
-0.59 (-4.43%)
Jun 3, 2026, 12:56 PM EDT - Market open
Assets$44.59M
Expense Ratio1.30%
PE Ration/a
Shares Out3.20M
Dividend (ttm)n/a
Dividend Yieldn/a
Ex-Dividend Daten/a
Payout Frequencyn/a
Payout Ration/a
Volume399,926
Open13.05
Previous Close13.22
Day's Range12.58 - 13.10
52-Week Low9.23
52-Week High72.16
Betan/a
Holdings12
Inception DateDec 2, 2024

About NVOX

Fund Home Page

The Defiance Daily Target 2X Long NVO ETF (NVOX) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to deliver 2x leveraged exposure to the daily share price movement of NOVO Nordisk A/S - ADR (NVO), less fees and expenses, through derivatives like swap agreements. NVOX was launched on Dec 2, 2024 and is issued by Defiance.

Asset Class Equity
Category Trading--Leveraged Equity
Stock Exchange NYSEARCA
Ticker Symbol NVOX
ETF Provider Defiance

Top 10 Holdings

266.41% of assets
NameSymbolWeight
NOVO-NORDISK SWAP MSn/a54.60%
NOVO-NORDISK SWAP NBC-Ln/a27.18%
NOVO-NORDISK SWAP MAREXn/a26.78%
NOVO-NORDISK SWAP CLEARSTREETn/a26.69%
NOVO-NORDISK A/S-SPONS ADR NOMURAn/a26.19%
NOVO-NORDISK INC SWAP CANTORn/a25.38%
OTHER ASSETS AND LIABILITIESn/a24.81%
NOVO-NORDISK SWAP BMO-Ln/a20.26%
US DOLLARSn/a19.31%
United States Treasury Bills 0%B.0 06.25.2615.21%
View More Holdings

Performance

NVOX had a total return of -77.79% in the past year, including dividends. Since the fund's inception, the average annual return has been -81.84%.

News

Defiance Launches NVOX, the First 2X Leveraged Single-Stock ETF on Novo Nordisk

MIAMI, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Defiance ETFs today launched NVOX, the world's first single-stock leveraged ETF for the pharmaceutical stock Novo Nordisk (NYSE: NVO). As the weight loss marke...

Other symbols: NVO
1 year ago - GlobeNewsWire